Your browser doesn't support javascript.
loading
GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma.
de Andrés, Mónica P; Jackson, Richard J; Felipe, Irene; Zagorac, Sladjana; Pilarsky, Christian; Schlitter, Anna Melissa; Martinez de Villareal, Jaime; Jang, Gun Ho; Costello, Eithne; Gallinger, Steve; Ghaneh, Paula; Greenhalf, William; Knösel, Thomas; Palmer, Daniel H; Ruemmele, Petra; Weichert, Wilko; Buechler, Markus; Hackert, Thilo; Neoptolemos, John P; Notta, Faiyaz; Malats, Núria; Martinelli, Paola; Real, Francisco X.
Affiliation
  • de Andrés MP; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, Madrid, Spain.
  • Jackson RJ; Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
  • Felipe I; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, Madrid, Spain.
  • Zagorac S; CIBERONC, Madrid, Spain.
  • Pilarsky C; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, Madrid, Spain.
  • Schlitter AM; Department of Surgery, Universitätsklinikum Erlangen, Erlangen, Germany.
  • Martinez de Villareal J; Institute of Pathology, School of Medicine, Technische Universitat Munchen, Munchen, Germany.
  • Jang GH; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Costello E; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, Madrid, Spain.
  • Gallinger S; CIBERONC, Madrid, Spain.
  • Ghaneh P; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Greenhalf W; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Knösel T; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Palmer DH; Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Ruemmele P; Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University, Toronto, Ontario, Canada.
  • Weichert W; Health Network, Toronto, Ontario, Canada.
  • Buechler M; Hepatobiliary/Pancreatic Surgical Oncology Program, University Health Network, Toronto, Ontario, Canada.
  • Hackert T; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Neoptolemos JP; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Notta F; Institute of Pathology, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Malats N; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
  • Martinelli P; Pathologisches Institute, Erlangen University Hospital, Erlangen, Germany.
  • Real FX; Institute of Pathology, School of Medicine, Technische Universitat Munchen, Munchen, Germany.
Gut ; 72(3): 535-548, 2023 03.
Article in En | MEDLINE | ID: mdl-36109153
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Gut Year: 2023 Type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Gut Year: 2023 Type: Article Affiliation country: Spain